z-logo
Premium
P1‐424: CHARACTERIZATION OF D‐ENANTIOMERIC PEPTIDES BINDING TO MONOMERIC AMYLOID BETA (1‐42) IDENTIFIED BY A COMPETITIVE MIRROR IMAGE PHAGE DISPLAY
Author(s) -
Rudolph Stephan,
Kutzsche Janine,
Klein Antonia Nicole,
Frenzel Daniel,
Willbold Dieter
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.667
Subject(s) - monomer , chemistry , enantiomer , peptide , amyloid (mycology) , phage display , in vitro , fibril , amyloid beta , biophysics , stereochemistry , biochemistry , crystallography , biology , polymer , organic chemistry , inorganic chemistry
The aim of this study is to assess the convenience of exploring longterm synergistic effects when multiple AD therapeutics of different mechanisms, fundamental and symptomatic, are combined. Methods: As a symptomatic drug, we selected donepezil, which have significant clinical benefits by activating undamaged cholinergic systems. From our previous study, as a fundamental drug, we prepared a small molecule KMSB600 that disassembles neurotoxic Ab aggregates back to inert Ab monomers and reverses the behavioral deficits in 2xTG-AD mice (APP/ PS1). During the oral co-administration, we performed Y-maze tasks every week for 4 months and performed fear conditioning tasks after the last trial of Y-maze. Ab plaques were visualized by thioflavin-S staining. Results: Co-administration of donepezil and KMSB600 significantly improved the deficits in the both behavior tests and histology study, compared to individual administration of donepezil or KMSB600 at the same dosages. Conclusions: Here, we report that co-administration of donepezil and KMSB600 significantly enhanced cognitive deficits in aged-AD mice in a complementary manner. Our findings imply that the cure of AD may require cocktail therapy of multiple drugs with different modes of action: cholinergic system improvement and amyloidogenic pathology reduction.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here